Immunoisolated xenogeneic chromaffin cell therapy for chronic pain: Initial clinical experience

Anesthesiology

Volumn 85, Issue 5, 1996, Pages 1005-1012

  Buchser, E ^a,b   Goddard, M ^c   Heyd, B ^b   Joseph, J M ^b   Favre, J ^b   De Tribolet, N ^b   Lysaght, M ^d   Aebischer, P ^b,e  

^a Hospital of Morges   (Switzerland)

^b University of Lausanne Medical Center   (Switzerland)

^c CytoTherapeutics Inc   (United States)

^d BROWN UNIVERSITY   (United States)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Catecholamines; Chromaffin cells; Chronic pain; Encapsulation; Enkephalins

Indexed keywords

ADULT; AGED; ANALGESIA; ANIMAL CELL; ARTICLE; CATTLE; CELL TRANSPLANTATION; CHROMAFFIN CELL; CHRONIC PAIN; CLINICAL ARTICLE; ENCAPSULATION; FEMALE; FOLLOW UP; HUMAN; MALE; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; TREATMENT OUTCOME; XENOGRAFT; ANIMAL; ARTIFICIAL MEMBRANE; CHRONIC DISEASE; DRUG DELIVERY SYSTEM; DRUG IMPLANT; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; PALLIATIVE THERAPY; TRANSPLANTATION; XENOTRANSPLANTATION;

ADULT; AGED; ANIMALS; CATTLE; CHROMAFFIN CELLS; CHRONIC DISEASE; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; FEMALE; HUMANS; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PALLIATIVE CARE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029967938     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199611000-00007     Document Type: Article

References (33)

1. Langer R, Vacanti JP: Tissue engineering. Science 1993; 260:920-6
2. Mulligan RC: The basic science of gene therapy. Science 1993; 260:926-32
3. Lindvall O: Prospects of transplantation in human neurodegenerative diseases. Trends Neurosci 1991; 14:376-84
4. Lysaght MJ, Frydel B, Emerich, Winn S: Recent progress in immunoisolated cell therapy. J Cell Biochem 1994; 56:196-203
5. Chick WL, Perna JJ, Lauris V, Low D, Galletti PM, Panol G, Whittemore AD, Like AA, Colton CK, Lysaght MJ: Artificial pancreas using living beta cells: effects on glucose homeostasis in diabetic rats. Science 1977; 197:780-2
6. Lim F, Sun AM: Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210:908-10
7. Aebischer P, Tresco PA, Winn SR, Greene LA, Jaeger CB: Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line. Exp Neurol 1991; 111:269-75
8. Aebischer P, Goddard M, Signore AP, Timson RL: Functional recovery in hemiparkinsonian primates transplanted with polymer encapsulated PC-12 cells. Exp Neurol 1994; 126:1-8
9. Hoffman D, Breakfield XO, Short P, Aebischer P: Transplantation of a polymer encapsulated cell line genetically engineered to release NGF. Exp Neurol 1993; 122:100-6
10. Sagot Y, Tan SA, Baetge E, Schmalbruch H, Kato AC, Aebischer P: Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse. Eur J Neurosci 1995; 7:1313-22
11. Liu HW, Ofosu FA, Chang PL: Expression of human factor IX by microencapsulated recombinant fibroblasts. Hum Gene Ther 1993; 4:291-301
12. Sagen J, Wang H, Tresco PA, Aebischer P: Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances. J Neurosci 1993; 13:2415-23
13. Sullivan SJ, Maki T, Borland KM, Mahoney MD, Solomon BA, Muller TE, Monaco AP, Chick WL: Biohybrid artificial pancreas: Long-term implantation studies in diabetic, pancreatectomized dogs. Science 1991; 252:718-21
14. Soon-Shiong P, Feldman E, Nelson R, Komtebedde J, Smidsrod O, Skjak-Braek G, Espevik T, Heitz R, Lee M: Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation 1992; 54:769-74
15. Scharp DW, Swanson CJ, Olack BJ, Latta PP, Hegre OD, Doherty EJ, Gentile FT, Flavin KS, Ansara MF, Lacy PE: Protection of encapsulated human islets implanted without immunosuppression in patients with type I and type II diabetes and in non-diabetic control subjects. Diabetes 1994; 43:1167-70
16. Soon-Shiong P, Heintz RE, Merideth N, Yao QX, Yao Z, Zheng T, Murphy M, Moloney MK, Schmehl M, Harris M, Mendez R, Mendez R, Sanford P: Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 1994; 343:950-1
17. Nicholas MK, Arnason BGW: Immunologic considerations in transplantation to the central nervous system, Neural Regeneration and Transplantation. Edited by FJ Seil. New York, A.R. Liss, 1989, pp 239-84
18. Widner H, Brundin P: Immunologic aspects of grafting in the mammalian central nervous system. Brain Res 1988; 472:287-324
19. Joseph JM, Goddard MB, Mills J, Padrun V, Zurn A, Zielinski B, Favre J, Gardaz JP, Mosimann F, Sagen J, Christenson L, Aebischer P: Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: A preclinical study for the treatment of cancer pain. Cell Transplant 1994; 3:355-64
20. Portenoy RK: Cancer pain management. Semin Oncol 1993; 20:19-35
21. Coupland RE: The natural history of the chromaffin cell - Twenty-five years on the beginning. Arch Histol Cytol 1989; 52:331-41
22. Yaksh TL, Reddy SVR: Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen. ANESTHESIOLOGY 1981; 54:451-67
23. Yaksh TL, Malmberg AB: Interaction of spinal modulatory receptor systems, Progress in Pain Research and Management, Vol. 1. Edited by HL Fields, JC Liebeskind. Seattle, IASP Press, 1994, pp 151-71
24. Sagen J, Pappas GD, Pollard HB: Analgesia induced by isolated bovine chromaffin cells implanted in rat spinal cord. Proc Natl Acad Sci USA 1986; 83:7522-6
25. Sagen J, Pappas GD: Morphological and functional correlates of chromaffin cell transplants in CNS pain modulatory regions. Ann N Y Acad Sci 1987; 495:306-33
26. Ginzburg R, Seltzer Z: Subarachnoid spinal cord transplantation of adrenal medulla suppresses chronic neuropathic pain behavior in rats. Brain Res 1990; 523:147-50
27. Wu HH, Wilcox GL, McLoon SC: Implantation of AtT-20 or genetically modified AtT-20/hENK cells in mouse spinal cord induced antinociception and opioid tolerance. J Neurosci 1994; 14:4806-14
28. Wu, HH, Lester BR, Sun Z, Wilcox GL: Antinociception following implantation of mouse B16 melanoma cells in mouse and rat spinal cord. Pain 1994; 56:203-10
29. Saitoh Y, Taki T, Arita N, Ohnishi T, Hayakawa T: Analgesia induced by transplantation of encapsulated tumor cells secreting beta-endorphin. J Neurosurg 1995; 82:630-4
30. Winnie AP, Pappas GD, Das Gupta TK, Wang H, Ortega JD, Sagen J: Subarachnoid adrenal medullary transplants for terminal cancer pain. A report of preliminary studies. ANESTHESIOLOGY 1993; 79:644-53
31. Foley KM, Yaksh TL: Another call for patience instead of patients. ANESTHESIOLOGY 1993; 79:637-40
32. Sagen J, Hama AT, Winn SR, Tresco PA, Aebischer P: Pain reduction by spinal implantation of xenogeneic chromaffin cells immunologically isolated in polymer capsules. Soc Neurosci Abstr 1993; 19:234
33. Aebischer P, Buchser E, Joseph JM, Favre J, de Tribolet N, Lysaght M, Rudnick S, Goddard M: Transplantation in humans of encapsulated xenogeneic cells without immunosuppression. A preliminary report. Transplantation 1994; 58:1275-7